Publications du Docteur Monsonego

Infection à papillomavirus humains (HPV) et pathologies associées, dépistage, prévention, diagnostic et traitement.

1. Epidémiologie HPV

VIN VAIN HPV PREVALENCE
Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Young Women

(Obstet Gynecol Jan 18,2018)

VIN-VAIN-HPV-PREVALENCE.jpg

Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease.

(Cancer Epidemiol Biomarkers Prev October 2014 23:10 1997-2008)

attribution-of-high-risk-human-papilloma

Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.

(Vaccine 30, 2012, 5215–5221)

JVAC13270-2.jpg

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial.

(Gynecol Oncol, January 2015)

prevalence-of-high-risk-human-papilloma-

Prévalence des génotypes d’HPV chez les femmes en France:implications pour le dépistage et la vaccination.

(Gynécol. Obstét. Fertil, 2013;41:305–313)

Prevalence-des-genotypes.jpg

Prévalence de l’infection à HPV en France, impact attendu de la vaccination et du dépistage pour la prévention du cancer du col utérin.

(Vaccine, 30, 2012, 5215‐522)

prevalence-de-l-infection-a-hpv-en-franc

2. Dépistage du cancer du col

Gynécologie Obstétrique Pratique 28/11/2017

Dépistage du cancer du col utérin : un tournant ?

depistage-cancer-uterin-un-tournant.jpg

(Gynécol Obstét Fertil 2001 ; 29 : 1-9) 

Cytologie en phase liquide dans le cadre d’un dépistage primaire du cancer du col utérin : une étude multicentrique.

Cytologie-en-phase-liquide-dans-le-cadre

Int. J. Cancer: 129, 691–701 (2011)

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.

Evaluation-of-oncogenic-human-papillomav

Br J Cancer. 2001 Feb 2;84(3):360-6.

Liquid-based cytology for primary cervical cancer screening: a multi-centre study.

liquid-based-cytology-for-primary-cervic

3. Vaccination HPV

Vaccination HPV dans la vraie vie : dix années d’expérience
mt Médecine de la Reproduction, Gynécologie

Endocrinologie, vol. 18, n◦ 1, janvier-février-mars 2016

jlemte00590.jpg

End of study safety, immunogenicity, and efficacy of quadrivalent (types 6, 11, 16, 18) recombinant vaccine in adult women 24 to 45 years of age.

Br J Cancer. 2011 Jun 28;105(1):28-37

end-of-study-safety-immunogenicity-and-e

Prévention du cancer du col utérin : enjeux et perspectives de la vaccination antipapillomavirus

(Gynecol Obstet Fertil, 2006 Mar ; 34 (3):189-201)

Prevention-du-cancer-du-col-uterin.jpg

Profil de sécurité des vaccins papillomavirus : mise au point
(2015)

CNGOF 2015

col_2_Monsonego_bat1_zb.jpg

Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. 

Vaccine 28 (2010) 8065–8072

Benefits-of-vaccinating-young-adult-wome

4. Optimisation de la colposcopie

(The FASE Study). (Gynecologic Oncology 125, 2012, 175–180)

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening

risk-assessment-and-clinical-impact-of-l

(Gynecologic Oncology 99, 2005, 160 – 168)

Performance of the Roche AMPLICOR Human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.

performance-of-the-roche-amplicor.jpg

(Int J Gynecol Cancer. 2006 Mar-Apr;16(2):591-8 )

Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.

human-papillomavirus-testing-improves-th

(Gynecol Obstet Fertil. 2004 Jan;32(1):62-74)

Colposcopie : apport du test HPV en pratique clinique.

colposcopie-apport-du-test-hpv-en-pratiq

5. Transmission / Rôle de l'homme

Male circumcision for prevention of oncogenic HPV infection — Author's reply.

Male-circumcision-for-prevention.jpg

Genital human papillomavirus infections: correlation of cytological, colposcopic and histological features with viral types in women and their male partners.

genital-human-papillomavirus-infections-

Genital infection with HPV in men: translating research into practice.

(Vaccine. 2011 Jan 17;29(4):624-8)

genital-infection-with-hpv-in-men-transl

6. Perception des femmes

Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries. 

psychological-impact-support-and-informa

Civil society: A critical new advocate for vaccination in Europe.

(Vaccine. 2011 Jan 17;29(4):624-8)

civil-society-a-critical-new-advocate-fo

Perception et impact psychologique du frottis anormal en France. Résultats comparatifs d’une enquête européenne. 

perception-et-impact-psychologique-du-fr

7. HPV / EUROGIN Roadmap - Consensus d'experts internationaux

Eurogin 2017 Roadmap: Triage strategies for the managment of HPV-positive women in cervical screening programs

Kate Cuschieri 1 , Guglielmo Ronco 2 , Attila Lorincz 3 , Laurie Smith4 , Gina Ogilvie5 , Lisa Mirabello6 , Francesca Carozzi7 , Heather Cubie8 , Nicolas Wentzensen6 , Peter Snijders9 , Marc Arbyn10, Joe Monsonego11 and Silvia Franceschi12

Int J Cancer. 2018 Aug 15;143(4):735-745

EUROGIN 2017 Roadmap.jpg

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines

Julia M.L. Brotherton1,2, Mark Jit3,4, Patti E. Gravitt5 , Marc Brisson6 , Aimee R. Kreimer 7 , Sara I. Pai8 , Carole Fakhry9 , Joseph Monsonego10 and Silvia Franceschi11

Int J Cancer. 2016 Aug 1;139(3):510-7

Brotherton_Roadmap_IJC_2016.jpg

EUROGIN 2012 roadmap on Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix

Maura L. Gillison1 , Xavier Castellsague2 , Anil Chaturvedi3 , Marc T. Goodman4 , Peter Snijders5 , Massimo Tommasino6 , Marc Arbyn7,8 and Silvia Franceschi6

Int J Cancer. 2014 Feb 1;134(3):497-507

eurogin-2012-roadmap.jpg

EUROGIN 2010 roadmap on cervical cancer prevention

Silvia Franceschi1 , Lynette Denny2 , Kathleen L. Irwin1*, Jose´ Jeronimo3 , Pier Luigi Lopalco4 , Joseph Monsonego5 , Julian Peto6 , Guglielmo Ronco7 , Peter Sasieni8 and Cosette M. Wheeler9

Int J Cancer. 2011 Jun 15;128(12):2765-74

eurogin-2011-roadmap.jpg

EUROGIN 2007 roadmap on cervical cancer prevention

eurogin-2007-roadmap-on-cervical-cancer.

EUROGIN 2007
Patient Education Conference Report
Part 2

eurogin-2007-roadmap-on-cervical-cancer.

EUROGIN 2004
Recommendations guidelines

(Gynecol Oncol. 2005 Mar;96(3):830-9.)

eurogin-2007-roadmap-on-cervical-cancer.

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice

Nicolas Wentzensen1 , Marc Arbyn2 , Johannes Berkhof3 , Mark Bower4 , Karen Canfell5 , Mark Einstein6 , Christopher Farley7 , Joseph Monsonego8 and Silvia Franceschi9

Int J Cancer. 2017 May 15;140(10):2192-2200

eurogin-roadmap2016-1.jpg

EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection

Anna R. Giuliano1 , Alan G. Nyitray2 , Aimee R. Kreimer 3 , Christine M. Pierce Campbell1 , Marc T. Goodman4 , Staci L. Sudenga1 , Joseph Monsonego5 and Silvia Franceschi6

Int J Cancer. 2015 Jun 15;136(12):2752-60

eurogin-2014-roadmap.jpg

EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease

Marc Arbyn1*, Silvia de Sanjosé2 , Mona Saraiya3 , Mario Sideri4 , Joel Palefsky5 , Charles Lacey6 , Maura Gillison7 , Laia Bruni2 , Guglielmo Ronco8 , Nicolas Wentzensen9 , Julia Brotherton10, You-Lin Qiao11, Lynnette Denny12, Jacob Bornstein13, Laurent Abramowitz14, Anna Giuliano15, Massimo Tommasino16, Joseph Monsonego17

Int J Cancer. 2012 Nov 1;131(9):1969-82

eurogin-2011-roadmap.jpg

EUROGIN 2008 roadmap on cervical cancer prevention

Silvia Franceschi1 , Jack Cuzick2 , Rolando Herrero3 , Joakim Dillner4 and Cosette M. Wheeler5*

Int J Cancer. 2009 Nov 15;125(10):2246-55

eurogin-2011-roadmap.jpg

EUROGIN 2007
Patient Education Conference Report
Part 1

eurogin-2007-roadmap-on-cervical-cancer.

EUROGIN 2006
Recommendations guidelines

EUROGIN 2003
Recommendations guidelines

eurogin-2007-roadmap-on-cervical-cancer.

8. Test HPV

Detection of Human Papillomavirus Genotypes Among High-Risk Women: A Comparison of Hybrid Capture and Linear Array Tests.

(Sex Transm Dis. 2008 May;35(5):521-7)

detection-of-human-papillomavirus-genoty

Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.

(Int J Gynecol Cancer. 2006 Mar-Apr;16(2):591-8 )

detection-of-human-papillomavirus-genoty

Immunocytochemistry in Liquid-Based Cytology Samples in Equivocal Pap Smears.

(Acta Cytol. 2007 Sep-Oct;51(5):755-66) 

detection-of-human-papillomavirus-genoty

9. Recherche

Papillomavirus et cancer du col de l’utérus.

papillomavirus-et-cancer.jpg

Estrogen and progesterone receptors in Cervical HPV related lesions.

(Gynecol Oncol. 2005 Mar;96(3):830-9.)

estrogen-and-progesterone.jpg

10. Condylome acuminé

Incidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en France.

(Gynecol Obstet Fertil. 2007 Feb;35(2):107-13)

Condylome-acumine.jpg

11. Anus

(Gynécologie Obstétrique & Fertilité, 38 (2010) 250–254)

Cancer anal et papillomavirus humains : une pathologie en miroir de celle du cancer du col utérin.

Cancer-anal-et-papillomavirus-humains.jp

12. Cancers ORL/Multifocaux

Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review.

(Oral Oncology 67 (2017) 138–145)

cancers-or-multifocaux.jpg

Date de dernière mise à jour : jeudi 24 avril 2019